Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score N/A
- Piotroski Score N/A
- Grade Perform
- Symbol (GBT)
- Company Global Blood Therapeutics, Inc.
- Price $68.49
- Changes Percentage (0.01%)
- Change $0.01
- Day Low $68.47
- Day High $68.49
- Year High $73.02
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses of Oxbryta in a Phase II a clinical trial of adolescent and pediatric patients with SCD. In addition, the company is developing its lead product candidate inclacumab, novel human monoclonal antibody, which is in Phase III a clinical trial to reduce the incidence of painful vaso-occlusive crises, and resulting hospital admissions; and GBT601, a hemoglobin polymerization inhibitor that is in Phase I development. It has a license and collaboration agreement with Syros Pharmaceuticals, Inc. to discover, develop, and commercialize therapies for SCD and beta thalassemia; and Sanofi S.A. to two early-stage research programs in SCD. Global Blood Therapeutics, Inc. was incorporated in 2011 and is headquartered in South San Francisco, California.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 11/03/2022
- Fiscal Year End N/A
- Average Stock Price Target $59.00
- High Stock Price Target $110.00
- Low Stock Price Target $36.00
- Potential Upside/Downside N/A
- Consensus Rating Buy
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$4.86
- Trailing P/E Ratio -14.081003289474
- Forward P/E Ratio -14.081003289474
- P/E Growth -14.081003289474
- Net Income $-303,091,000
Income Statement
Quarterly
Annual
Latest News of GBT
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Transgender asylum seekers find hope through San Francisco's LGBT Asylum Project
Transgender individuals are seeking asylum in the US to escape persecution and violence in their home countries. Jose Martinez covers their stories on KPIX, available on YouTube, Facebook, Instagram, ...
By CBS News | 12 hours ago -
Transgender asylum seekers find hope through SF LGBT Asylum Project
Transgender individuals seek asylum in the U.S. to escape persecution. Kiki Lopez from the Philippines found refuge in San Francisco through the LGBT Asylum Project, supporting asylum seekers facing d...
By CBS News | 12 hours ago -
'The Holiday' Gets an LGBTQ Twist in 'The Holiday Exchange' Trailer Starring Taylor Frey and Rick Cosnett (Exclusive)
"The Holiday Exchange" is a new LGBTQ twist on a Christmas movie favorite, featuring Taylor Frey, Rick Cosnett, and Kyle Richards. The film follows Wilde and Oliver as they swap houses and find romanc...
By PEOPLE.com | 3 days ago
